This study is consistent with recent reports on xenografts derived from breast cancer [19] and hepatocellular carcinoma (HCC) CTCs [20], providing the proof of principle about the metastatic potential of EpCAM-positive CTCs. The gene discussed is EPCAM; the disease is breast carcinoma.